Evolution of Mayaro virus and its impact on transmission by urban vectors

马亚罗病毒的进化及其对城市媒介传播的影响

基本信息

项目摘要

Abstract Mayaro virus (MAYV) is the second leading cause of alphavirus-induced febrile illness in South American countries. In recent years, MAYV has gained significant attention because its geographic distribution is expanding north from South and Central America into the Caribbean Islands. While sporadic cases of MAYV were reported in past years, it is still unclear why MAYV outbreaks of considerable proportion are now being recognized more frequently in Latin America and what factors are accounting for the expansion of the virus to new geographic areas. Recently, eco-epidemiological investigations have confirmed the presence of naturally infected Aedes aegypti in Brazil. This raises the possibility that adaptation of MAYV to be better transmitted by urban vectors is a major contributing factor to the emergence and expansion of this pathogen. Thus, studies are urgently needed to assess this possibility. Given the expansion of MAYV into new geographic areas and the evidence supporting urban transmission, we conducted vector competence studies with Aedes aegypti and Aedes albopictus and MAYV strains isolated during years of low (2002) or high MAYV transmission (2011) in Peru. We observed that a MAYV strain isolated during an outbreak in 2011 had greater frequency of infection, dissemination, and transmission in both Aedes aegypti and Aedes albopictus, whereas minimal to no transmission was detected with the strain isolated in 2002, a year of low MAYV transmission. In the studies of this proposal, we hypothesize that MAYV is adapting to be better transmitted by Aedes aegypti and Aedes albopictus and that evolutionary changes in the E2 glycoprotein of the MAYV genome promote enhanced infectivity in these mosquito vectors. We will: 1) examine the vector competence of urban vectors for circulating MAYV strains in Peru, using a susceptible animal model and 2) conduct genetic studies to assess E2 glycoprotein mutations and their contribution to vector competence. Completion of this study will provide critical knowledge to our understanding of MAYV transmission and will identify and experimentally validate viral genes associated with enhanced transmission. It will also generate powerful tools, including the development of reverse genetic systems, for studying other aspects of MAYV infection. Therefore, this project represents an important step towards our long-term objective of understanding the emergence mechanism of MAYV.
抽象的 Mayaro病毒(Mayv)是南美α诱导的高温疾病的第二大主要原因 国家。近年来,梅夫(Mayv)受到了极大的关注,因为其地理分布是 从南美洲和中美洲向北扩展到加勒比群岛。而零星的疾病 在过去的几年中报道了,目前尚不清楚为什么现在有相当比例的爆发 在拉丁美洲认识到更频繁的频率,以及哪些因素将病毒扩展到 新地理区域。最近,生态流行病学研究已经证实了自然存在 在巴西被感染的埃及埃及。这增加了Mayv改编更好地传播Mayv的可能性 城市媒介是导致该病原体出现和扩展的主要因素。因此,研究是 迫切需要评估这种可能性。 鉴于Mayv扩展到新的地理区域以及支持城市传播的证据, 我们通过伊蚊和艾德斯白化菌和Mayv菌株进行了矢量能力研究。 在低年度(2002年)或秘鲁的高贫民传输(2011年)中。我们观察到分离的Mayv菌株 在2011年的一次爆发中,两种艾德斯的感染,传播和传播的频率更高 埃及和艾德斯白化病,而在2002年分离的菌株中,检测到最小至未传播 一年的低MAYV传播。在该提案的研究中,我们假设Mayv正在适应 埃及埃及和艾德斯白化菌和E2糖蛋白的进化变化更好地传播 在这些蚊子载体中,Mayv基因组促进了增强的感染性。我们将:1)检查向量 使用易感动物模型和2) 进行遗传研究以评估E2糖蛋白突变及其对载体能力的贡献。 这项研究的完成将为我们对Mayv传播的理解提供关键知识,并将 识别和实验验证与增强传播相关的病毒基因。它也会生成 强大的工具,包括开发反向遗传系统,用于研究Mayv的其他方面 感染。因此,该项目是朝着我们理解的长期目标迈出的重要一步 Mayv的出现机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patricia Veronica Aguilar其他文献

Patricia Veronica Aguilar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patricia Veronica Aguilar', 18)}}的其他基金

Thermostable Inactivated Potent Yellow Fever Vaccine
耐热灭活强效黄热病疫苗
  • 批准号:
    10325436
  • 财政年份:
    2021
  • 资助金额:
    $ 24万
  • 项目类别:
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
哥伦比亚-美国
  • 批准号:
    10376263
  • 财政年份:
    2016
  • 资助金额:
    $ 24万
  • 项目类别:
Research Training Program on the Impact of Zoonotic and Vector-borne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile Illnesses
关于人畜共患病和媒介传播病毒、立克次体和钩端螺旋体对急性未分化发热性疾病影响的研究培训计划
  • 批准号:
    9884659
  • 财政年份:
    2016
  • 资助金额:
    $ 24万
  • 项目类别:
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
哥伦比亚-美国
  • 批准号:
    10240140
  • 财政年份:
    2016
  • 资助金额:
    $ 24万
  • 项目类别:
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
哥伦比亚-美国
  • 批准号:
    10577786
  • 财政年份:
    2016
  • 资助金额:
    $ 24万
  • 项目类别:
Hijacking of cellular pathways by novel tick-borne phlebovirus
新型蜱传白蛉病毒劫持细胞通路
  • 批准号:
    9088328
  • 财政年份:
    2015
  • 资助金额:
    $ 24万
  • 项目类别:
Naturally occurring human antibodies to alphavirus infection
天然存在的人类抗甲病毒感染抗体
  • 批准号:
    8512211
  • 财政年份:
    2013
  • 资助金额:
    $ 24万
  • 项目类别:
Naturally occurring human antibodies to alphavirus infection
天然存在的人类抗甲病毒感染抗体
  • 批准号:
    8652431
  • 财政年份:
    2013
  • 资助金额:
    $ 24万
  • 项目类别:

相似国自然基金

艾德莱斯织物纹样建模技术研究
  • 批准号:
    61002050
  • 批准年份:
    2010
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Assessing the roles of viral mutations and host factors in the transmission of Mayaro virus and other alphaviruses by urban mosquitoes
评估病毒突变和宿主因素在城市蚊子传播马亚罗病毒和其他甲病毒中的作用
  • 批准号:
    10663696
  • 财政年份:
    2023
  • 资助金额:
    $ 24万
  • 项目类别:
HSP90 paralog selective small molecules as anti-old-world alpha-viral therapeutic leads.
HSP90 旁系同源选择性小分子作为抗旧世界 α 病毒治疗先导药物。
  • 批准号:
    10753347
  • 财政年份:
    2023
  • 资助金额:
    $ 24万
  • 项目类别:
Human Monoclonal Antibodies for Encephalitic Alphaviruses
脑炎甲病毒的人单克隆抗体
  • 批准号:
    10539155
  • 财政年份:
    2022
  • 资助金额:
    $ 24万
  • 项目类别:
Mechanisms of alphavirus infectivity and adaptation - Resubmission - 1
甲病毒感染性和适应机制 - 重新提交 - 1
  • 批准号:
    10556424
  • 财政年份:
    2022
  • 资助金额:
    $ 24万
  • 项目类别:
Mechanisms of alphavirus infectivity and adaptation - Resubmission - 1
甲病毒感染性和适应机制 - 重新提交 - 1
  • 批准号:
    10444392
  • 财政年份:
    2022
  • 资助金额:
    $ 24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了